Why the study?
Does intensive stepped-care treatment reduce five-year mortality in patients with mild hypertension compared to usual community care?
Does intensive stepped-care treatment reduce five-year mortality in patients with mild hypertension compared to usual community care?
Intensive stepped-care treatment significantly reduces five-year mortality in patients with mild hypertension compared to usual community care, supporting early treatment before end-organ damage occurs.
Answers are grounded in this paper and cite their sources.
Supports stepped-care intensification in mild hypertension; confirms mortality benefit versus usual care in this RCT.
In the Hypertension Detection and Follow-up Program, 7825 (71.5 per cent) of the 10,940 participants had diastolic blood pressures averaging between 90 and 104 mm Hg on entry into the study and were designated Stratum 1. Half were referred to their usual source of care in the community (the referred-care group), and half were treated intensively in special clinics (the stepped-care group). Five-year mortality in the Stratum 1 patients given stepped care was 20.3 per cent lower than in those given referred care (P less than 0.01). Particularly noteworthy was the beneficial effect of stepped-care treatment on persons with diastolic pressures of 90 to 104 mm Hg who had no evidence of end-organ damage and were not receiving antihypertensive medication when they entered the study. This subgroup had 28.6 per cent fewer deaths at five years among those treated with stepped care than among those treated with referred care (P less than 0.01). These findings support a recommendation that in patients with mild hypertension, treatment should be considered early, before damage to end organs occurs.
No takes yet. Share an insight, caveat, or question.
A 1982 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: